Corteva (NYSE:CTVA) PT Raised to $67.00

Corteva (NYSE:CTVA) had its price objective lifted by analysts at Oppenheimer from $62.00 to $67.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s price objective would indicate a potential upside of 24.84% from the company’s previous close.

Other analysts have also recently issued research reports about the stock. Wolfe Research began coverage on shares of Corteva in a research note on Friday, March 1st. They set an “outperform” rating and a $67.00 target price on the stock. Wells Fargo & Company boosted their target price on shares of Corteva from $54.00 to $65.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. KeyCorp boosted their target price on shares of Corteva from $63.00 to $66.00 and gave the company an “overweight” rating in a report on Tuesday, April 9th. UBS Group cut their price objective on shares of Corteva from $65.00 to $64.00 and set a “buy” rating on the stock in a research report on Thursday, January 11th. Finally, Mizuho decreased their target price on Corteva from $59.00 to $56.00 and set a “buy” rating for the company in a research report on Thursday, February 1st. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $63.29.

Corteva Stock Performance

NYSE CTVA opened at $53.67 on Tuesday. The firm’s fifty day moving average price is $55.17 and its two-hundred day moving average price is $50.20. The stock has a market cap of $37.51 billion, a PE ratio of 52.62, a PEG ratio of 1.40 and a beta of 0.77. Corteva has a fifty-two week low of $43.22 and a fifty-two week high of $63.06. The company has a debt-to-equity ratio of 0.09, a quick ratio of 0.90 and a current ratio of 1.56.

Corteva (NYSE:CTVA) last posted its earnings results on Thursday, February 1st. The company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.09. The firm had revenue of $3.71 billion for the quarter, compared to analysts’ expectations of $3.54 billion. Corteva had a net margin of 4.27% and a return on equity of 7.43%. During the same quarter in the previous year, the firm posted $0.16 earnings per share. On average, equities analysts expect that Corteva will post 2.86 EPS for the current fiscal year.

Hedge Funds Weigh In On Corteva

Hedge funds and other institutional investors have recently modified their holdings of the business. Rise Advisors LLC boosted its stake in shares of Corteva by 2,522.2% in the 1st quarter. Rise Advisors LLC now owns 472 shares of the company’s stock worth $27,000 after buying an additional 454 shares during the last quarter. Cornerstone Planning Group LLC purchased a new position in Corteva in the second quarter valued at approximately $28,000. CVA Family Office LLC purchased a new position in Corteva in the fourth quarter valued at approximately $25,000. Ironwood Wealth Management Inc. raised its holdings in Corteva by 106.1% during the 1st quarter. Ironwood Wealth Management Inc. now owns 544 shares of the company’s stock valued at $31,000 after acquiring an additional 280 shares during the period. Finally, PCA Investment Advisory Services Inc. bought a new stake in Corteva during the 2nd quarter valued at $31,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

About Corteva

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.